Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It was mentioned in one of the recent messages, that the company was working towards “safeguarding investors’ interests”. No sign of any such activity. On the other hand, market makers have acquired a freehand to treat this share as they wish. What exactly is happening? Really miserable feeling to watch this kind of decline in the sp, while the company is making good progress in developing and marketing new therapies for oncological and immunological conditions.
Has the management got to say anything about this poor sp? Finally, being remotely helpful, can this low low valuation trigger interest in M&A activity?
Given the small free float a share buy back would make a noticeable difference, this has become standard with many companies on both sides of the pond actively buying back shares.
Worth checking the LSE RNS first thing in the morning to see just how prolific it is, perhaps if a few of us on here suggest it then it may get tabled at next AGM.
Here's a search of today's RNS release on share buy backs, no less than 4 pages
https://www.londonstockexchange.com/news?tab=news-explorer&headlines=76
I know there's not many on his board, but could I suggest copying above link along with a note and sending into the board for airing - if anyone needs contact details I can post here.
Resolution 5 of last years AGM which received almost 100% of votes cast
5. To grant a general mandate to the Directors to repurchase shares of the Company.
I think that resolution is always there and I can't see them doing Buybacks for years......they seem to be inept when it comes tro shareholders interests or strategic actions rto build shareholder value. Almost a vanity Project for CKHH.....
Unbelievably this is 30% off from the high hit with the FDA approval of Fruq.
Re: Buy backs, there is still much spending to be done to get to cash flow positive from sales and royalties alone, but as they dont expect to raise more capital they are likely to end up in a position where they have excess capital….but that is an issue for a few years time.
In the short term they should buy in the market as treasury shares to meet share awards to staff and Directors.
Appears outright deliberate act. Is there any reason for this decline this share is experiencing?
After having sold its shares in public offering, 3 years ago at HKSE, more than twice the present price, at what “attractive” price would the company be willing to buy back?
A great opportunity for a larger company to acquire
Its difficult to rally investors to write to companies, for what ever reason there is a block - shareholders just do not like doing it, therefore change is hard without some form of engagement.
If you have sent an email please post as it may encourage others.
Jatw, yes, treasury shares would be the way to go serving both the company and shareholders.
Wincanton just got bid for today
Wincanton to go private – with board fed up with share price underperformance
https://www.cityam.com/wincanton-to-go-private-with-board-fed-up-with-share-price-underperformance/
Investor Enquiries
ir@hutch-med.com
I will email them - the least they could do is update the out of date pipleline which was last changed in July 2023!
Luckily, it’s weekend and a pause for the agonising slump in the share price and diminishing market value. Regarding getting any kind of response from i.r, good luck to those trying to contact.
Management will be feeling the pinch too, as will employees many with options.
just checked my inbox and that email address below is the same one I have used, always received a reply and on one occasion a telephone call from director.
I have been assured they will submit recommendations at the next board meeting, provided these are within the general remit.
amones, its worth a shot, some replies can take a couple of weeks in my experience.
One concern is about the rapid decline in the sp despite all the good achievements, including marketing a product in US market and also, impending outcome of application for approval for the same drug in Japan and Europe (plus many more). Over the last 3 weeks, sp has fallen by a quarter and the management is yet to say anything.
Regarding getting a reply from the company- 3 years ago, Mr Hogg, (then CEO), had replied to me, in detail, to an email enquiry arising from discussion on this board. He had taken time to respond a private investor’s query. However, I did not receive any response to another email to the investor relations, an year and half age. (Mr Hogg had retired by that time). Pencil , please inform other users of this bb If you get a response from the ir.
The interesting thing about Christian is that he did look at this bulletin board occasionally and was always keen on picking up investor sentiment. I don't get the impression the current senior leadership team have the same interest in investors.
A few weeks ago I sold my entire holding and invested it in Nvidia. I have finally given up with the Geo Political risks here. It doesn't seem to matter how successful the Company is or will become, the market and investors are not buying it. I have invested too much time and effort and became emotionally attached to Hucthmed, which is probably not a good thing. Good luck to everyone.
During Mr Hogg’s period, HCM used to get very good coverage in the financial sections of the press, with it’s stock price always in a healthy range. Markets used to treat the company fairly due to its decent pipeline. Now, the picture entirely different. The company has progressed very well with R&D, successfully getting approval for its drug candidates and marketing the same. Also, company has made alliances with other major players in the field resulting in significant royalties. While continuing to do productive progress and having no debts (correct me if I’m wrong) , it has failed to bring cheers to the investors. Share price is less than half its value 2 years ago and has fallen more than 30% since the beginning of the new year. The least, the management could do to help is to release a statement, whether they are ( /are not ) able to see any reason/s for decline in the market valuation.
Absence of a dedicated CEO seems to be the matter.
Hoping to see better days ahead!
It could be emails are getting stuck in junk folders, this has happened to me also - try adding Mark Lee, Senior Vice President to subject line, this helped a colleague of mine.
If you still have problems try contacting Tim.Stamper@fticonsulting.com, he can then help pass on messages.
Hutchmed seem to be doing everything right, nothing I can see adverse - hunker down and wait for the storm to pass.
Alibaba co-founders buy more than $200 million worth of shares, sending stock up
https://www.cnbc.com/2024/01/23/alibaba-stock-jack-ma-joe-tsai-buy.html
S4 has today announced a share buy back programme, shares currently up 7%
Is there a similar online chat forum for HK shareholders to express their concerns and views?On an average, 3 million shares are traded daily at HKSE. What factors might be encouraging buyers over there to buy into this stock?
Has anyone received a reply from the ir department? Luckily, another weekend….
I think the main issue here now is China, teh entire market and anything Chinese is now considered univestible by most Fund Managers and the entire Chinese market is sinking, fuelled by an impending property sector collapse